For instance, serum tumor markers such as carcinoembryonic antigen (CEA) [44], cytokeratin 19 fragment (CYFRA 21-1) [45], and neuron-specific enolase (NSE) [46] reflect disease severity and treatment outcomes through concentration fluctuations. The gene discussed is KRT19; the disease is neoplasm.